This is the authors' abstract. We don't add key points for this paper.
In 2006, a couple of professional cycling teams initiated their own testing programs. The objective of this study is to describe fluctuations in commonly measured blood parameters among top-level riders. From December 12th 2006 to November 30th 2007, a total of 374 blood samples and 287 urine samples were obtained from 28 elite, male cyclists. Blood was analyzed for hematocrit (Hct), hemoglobin concentration ([Hb]) and % reticulocytes. Seventy-six percent of all samples were collected out-of-competition (OOC). From December 2006 to September 2007, the average Hct and [Hb] decreased by 4.3 percent point and 1.3 g/dL, respectively. After the end of the competitive season, the values increased back to baseline levels. During the Tour de France, the [Hb] decreased by 11.5 %, with individual decreases ranging from 7.0 to 20.6 %. Hct and [Hb] values were lower in-competition (40.9 % and 14.1 g/dL) compared to OOC (43.2 % and 15.0 g/dL) and pre-competition (43.5 % and 14.9 g/dL). Our results suggest that when interpreting blood sample results in an anti-doping context, the sample timing (OOC, pre- or in-competition) and time of year should be kept in mind.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Mørkeberg et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: